bioRxiv · 10.1101/2024.05.13.594017
Distinct evolutionary patterns of tumor immune escape and elimination determined by ECM architectures
Abstract
Cancer progression remains a significant clinical challenge. Phenotypic adaptation by tumor cells results in disease hetero-geneity, which drives treatment resistance and immune escape. T cell immunotherapy, while effective at treating some cancer subtypes, can also fail due to limits on tumor immunogenicity or T cell recognition. For example, one potential contributor to immune escape involves the density and alignment of the extracellular matrix (ECM) surrounding tumors, also known as Tumor-Associated Collagen Signature (TACS). However, the specific mechanisms by which aligned fibers contribute to decreased patient survival rates have not yet been decoupled. Here, we developed our EVO-ACT (EVOlutionary Agent-based Cancer T cell interaction) model to study how TACS affects tumor evolution and dynamic tumor-T cell interactions. We identified a variety of TACS-specific dynamical features that influence T cell infiltration, cancer immunoediting, and ultimate immune escape. Our model demonstrates how TACS and phenotypic adaptation together explain overall survival trends in breast cancer.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Fan, Y., George, J. T.. 2024-05-15. Distinct evolutionary patterns of tumor immune escape and elimination determined by ECM architectures. https://doi.org/10.1101/2024.05.13.594017
Cite the original work for its findings. Save a collection to share your selection of sources.